0001437749-19-005607.txt : 20190325 0001437749-19-005607.hdr.sgml : 20190325 20190325161713 ACCESSION NUMBER: 0001437749-19-005607 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190321 FILED AS OF DATE: 20190325 DATE AS OF CHANGE: 20190325 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chavez Christopher G. CENTRAL INDEX KEY: 0001192858 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37525 FILM NUMBER: 19702861 MAIL ADDRESS: STREET 1: 5830 GRANITE PKWY, STE 1100 CITY: PLANO STATE: TX ZIP: 75024 FORMER NAME: FORMER CONFORMED NAME: CHAVEZ CHRISTOPHER G DATE OF NAME CHANGE: 20020925 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nuvectra Corp CENTRAL INDEX KEY: 0001648893 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 300513847 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5830 GRANITE PKWY STREET 2: SUITE 1100 CITY: PLANO STATE: TX ZIP: 75024 BUSINESS PHONE: 972-668-4107 MAIL ADDRESS: STREET 1: 5830 GRANITE PKWY STREET 2: SUITE 1100 CITY: PLANO STATE: TX ZIP: 75024 FORMER COMPANY: FORMER CONFORMED NAME: QIG GROUP, LLC DATE OF NAME CHANGE: 20150722 4 1 rdgdoc.xml GRANT X0306 4 2019-03-21 0001648893 Nuvectra Corp NVTR 0001192858 Chavez Christopher G. 5830 GRANITE PKWY, STE 1100 PLANO TX 75024 1 Restricted Stock Unit 0 2019-03-21 4 A 0 3873 0 A 2019-06-21 2020-03-21 Common Stock 3873 3873 D Stock Option (right to buy) 12.62 2019-03-21 4 A 0 6455 0 A 2019-06-21 2029-03-21 Common Stock 6455 28776 D Grant of restricted stock units, which vests in four equal quarterly installments beginning on June 21, 2019. Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Grant of stock options, which vests in four equal quarterly installments beginning on June 21, 2019. /s/ Melissa G Beare as attorney in fact for Christopher G Chavez 2019-03-25 EX-24 2 poachavez.htm POWER OF ATTORNEY ex_138820.htm

 

Exhibit 24

 

NUVECTRA CORPORATION

 

LIMITED POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS

 

Know all by these presents, that the undersigned hereby constitutes and appoints each of Walter Berger, Melissa Beare, Jennifer Kosharek and David C. Johnson, or either of them acting singly and with full power of substitution, the undersigned's true and lawful attorney-in-fact to:

 

1.     execute for and on behalf of the undersigned, in the undersigned's capacity as an officer or director or both of Nuvectra Corporation, a Delaware corporation (the "Company"), Forms 3, 4 and 5 (and any amendments thereto) in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the rules thereunder;

 

2.      perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5, complete and execute any amendments thereto, and timely file such form with the U.S. Securities and Exchange Commission (the "SEC") and any securities exchange or similar authority, including without limitation the filing of a Form ID or any other documents necessary or appropriate to enable the undersigned to file the Forms 3, 4 and 5 electronically with the SEC;

 

3.     seek or obtain, as the undersigned's representative and on the undersigned's behalf, information on transactions in the Company's securities from any third party, including brokers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such person to release any such information to each of the undersigned's attorneys-in-fact appointed by this Limited Power of Attorney and approves and ratifies any such release of information; and

 

4.     take any other action in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by or for, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Limited Power of Attorney shall be in such form and shall contain such information and disclosure as such attorney-in-fact may approve in such attorney-in-fact's discretion.

 

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever required, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this Limited Power of Attorney and the rights and powers herein granted.

 

The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request and on the behalf of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with, or any liability for the failure to comply with, any provision of Section 16 of the Exchange Act. 

 

This Limited Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 or 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to each of the foregoing attorneys-in-fact.

 

IN WITNESS WHEREOF, the undersigned has executed this Limited Power of Attorney to be effective as of February 1, 2019.

 

 

Signed and acknowledged:
   
 

/s/ Christopher G. Chavez

Signature

 

Christopher G. Chavez